Secondary chronic myelogenous leukemia after chemotherapy followed by adjuvant radiotherapy for small cell lung cancer

Leukemia Research

Volumn 23, Issue 10, 1999, Pages 961-964

  Waller, C F ^a   Fetscher, S ^a   Lange, W ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Chemotherapy; CML; Radiotherapy; Secondary leukemia; Small cell lung cancer

Indexed keywords

CARBOPLATIN; CISPLATIN; EPIRUBICIN; ETOPOSIDE; IFOSFAMIDE;

ADULT; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RADIOTHERAPY; CANCER RISK; CASE REPORT; CHRONIC MYELOID LEUKEMIA; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG SMALL CELL CANCER; MALE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SECOND CANCER;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, SMALL CELL; HUMANS; LEUKEMIA, MYELOID, CHRONIC; LEUKEMIA, RADIATION-INDUCED; LUNG NEOPLASMS; MALE; NEOPLASMS, SECOND PRIMARY;

EID: 0032822020     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0145-2126(99)00114-9     Document Type: Article

References (22)

1. Levine E.G., Bloomfield C.D. Leukemias and myelodysplastic syndromes secondary to drug, radiation, and environmental exposure. Sem. Oncol. 19:1992;47.
2. Kaldor J.M., Day N.E., Clarke A., Van Leeuwen F.E., Henry-Amar M., Fiorentino M.V. et al. Leukemia following Hodgkin's disease. N. Engl. J. Med. 322:1990;7.
3. Moloney W.C. Radiogenic leukemia revisited. Blood. 70:1987;905.
4. Boice J.D., Blettner M., Kleinerman R.A., Stovall M., Moloney W.C., Engholm G. et al. Radiation dose and leukemia risk in patients treated for cancer of the cervix. J. Natl. Cancer. Inst. 79:1987;1295.
5. Whang-Peng J., Young R., Lee E., Longo D., Schechter G., DeVita V. Cytogenetic studies in patients with secondary leukemia/dysmyelopoietic syndrome after different treatment modalities. Blood. 71:1988;403.
6. Aguiar R.C. Therapy-related chronic myeloid leukemia: an epidemiological, clinical and pathogenetic appraisal. Leuk. Lymphoma. 29:1998;17.
7. Waller C.F., Fetscher S., Lange W. Treatment-related chronic myelogenous leukemia. Ann Hematol 1999 (in press).
8. Pedersen-Bjergaard J., Brondum-Nielsen K., Karle H., Johansson B. Chemotherapy-related-and late occuring-Philadelphia chromosome in AML, ALL and CML. Similar events related to treatment with DNA topoisomerase II inhibitors. Leukemia. 11:1997;1571.
9. Hashimi L., Al-Katib A., Mertelsmann R., Mohamed A.N., Koziner B. Cytofluorometric detection of chronic myelocytic leukemia supervening in a patient with chronic lymphocytic leukemia. Am. J. Med. 80:1986;269.
10. Whang-Peng J., Gralnick H.R., Johnson R.E., Lee E.C., Lear A. Chronic granulocytic leukemia (CGL) during the course of chronic lymphocytic leukemia (CLL): correlation of blood, marrow, and spleen morphology and cytogenetics. Blood. 43:1974;333.
11. Berman E., Strife A., Wisniewski D., Desai S., Gulati S., Jhanwar S., Clarkson B. Duration of the preclinical phase of chronic myelogenous leukemia: a case report. Blood. 78:1991;2969.
12. Blayney D.W., Longo D.L., Young R.C., Greene M.H., Hubbard S.M., Postal M.G. et al. Decreasing risk of leukemia with prolonged follow-up after chemotherapy and radiotherapy for Hodgkin's disease. N. Engl. J. Med. 316:1987;710.
13. Jackson G., Latham J., Lennard A., Taylor R., Proctor J. Rapid onset of chronic granulocytic leukaemia after treatment of Hodgkin's disease. Br. J. Haematol. 87:1994;193.
14. Meadows A.T., Baum E., Fossati-Bellani F., Green D., Jenkin R., Marsden B. et al. Second malignant neoplasms in children: an update from the Late Effects Study Group. J. Clin. Oncol. 3:1985;532.
15. Robinson B., Colls B., Fitzharris B., Atkinson C. Second malignant neoplasms in patients with Hodgkin's disease. Aust. NZ. J. Med. 24:1994;368.
16. Rosner F.&, Grünwald H. Hodgkin's disease and acute leukemia. Am. J. Med. 58:1975;339.
17. 131I for thyroid carcinoma. Cancer. Genet. Cytogenet. 55:1991;217.
18. Glicksman A.S., Pajak T.F., Gottlieb A., Nis N., Stutzman L., Cooper M.R. Second malignant neoplasms in patients successfully treated for Hodgkin's disease: a Cancer and Leukemia Group B study. Cancer Treat. Rep. 66:1982;1035.
19. Fetscher S., Finke J., Engelhardt R., Mertelsmann R., Lange W. Early-onset secondary malignancies after high-dose chemotherapy and autologous hematopoietic stem cell transplantation. Ann. Hematol. 74:1997;73.
20. Kamada N., Uchino H. Chronologic sequence in appearance of clinical and laboratory findings characteristic of chronic myelocytic leukemia. Blood. 51:1978;843.
21. Canellos G.P., Whang-Peng J. Philadelphia-chromosome-positive preleukaemic state. Lancet 1972;i,1227.
22. Biernaux C., Loos M., Sels A., Huez G., Stryckmans P. Detection of major bcr-abl gene expression at a very low level in blood cells of some healthy individuals. Blood. 86:1995;3118.